SAN DIEGO & VANCOUVER, British Columbia--(BUSINESS WIRE)--Sophiris Bio Inc. (NASDAQ: SPHS) (the “Company” or “Sophiris”), a biopharmaceutical company developing PRX302 for the treatment of urological diseases, today announced that Randall E. Woods, president and chief executive officer, will present a corporate overview at the 14th Annual Needham Healthcare Conference. The presentation is scheduled for Wednesday, April 15, 2015 at 2:20 p.m. EDT in New York City.
Help employers find you! Check out all the jobs and post your resume.
